Skip to content

Evaluation of the Titan 3-D™ Wedge System

A Multicenter, Prospective, Post-Market Clinical Follow-Up Evaluation of the Titan 3-D™ Wedge System

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03421665
Enrollment
0
Registered
2018-02-05
Start date
2018-06-15
Completion date
2022-09-01
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flat Foot, Lateral Column Lengthening, Medial Cuneiform Osteotomy

Keywords

titanium wedge, Evans, Cotton

Brief summary

Evaluate clinical healing and radiographic maintenance of correction following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Subjects who receive one or more TITAN 3-D™ Wedges will obtain satisfactory levels of clinical healing and radiographic maintenance of correction at 6 months.

Interventions

DEVICETitan 3D Wedge System

Each subject will undergo an LCL procedure and/or medial cuneiform osteotomy with one or more TITAN 3-D™ Wedges. Ancillary fixation should be used in conjunction with each TITAN 3-D™ Wedge used. This surgical procedure will be performed as standard of care and is not part of the research procedures. Post-operative care and weight-bearing/activity restrictions will be at the discretion of the surgeon as part of their standard of care for the procedure.

Sponsors

Paragon 28
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. The subject has foot pain/discomfort on the foot in question. 2. The subject has activity limitations due to the foot in question. 3. The subject agrees to comply with the requirements of the study and complete the study measures. 4. The subject (or representative of the subject in the case of a minor) is willing and able to provide written informed consent. 5. The subject plans on undergoing an LCL procedure and/or medial cuneiform osteotomy with a TITAN 3-D™ Wedge.

Exclusion criteria

1. The subject is pregnant. 2. The subject had been previously sensitized to titanium. 3. The subject is scheduled for a same day bilateral LCL procedure or medial cuneiform osteotomy procedure. 4. The subject is not expected to complete the study according to the investigation plan. 5. The subject has been deemed physiologically or psychologically inadequate by the enrolling physician. 6. The subject is: a prisoner, unable to understand what participation in the study entails, mentally incompetent, a known abuser of alcohol and/or drugs or anticipated to be non-compliant.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Healing6 MonthsEvaluate clinical healing following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Clinical healing is defined as lack of pain over the osteotomy site.
Radiographic Maintenance of Correction6 MonthsEvaluate radiographic maintenance of correction following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Radiographic maintenance of correction is defined as the absence of a clinically relevant change in radiographic measures across post-operative time points.

Secondary

MeasureTime frameDescription
Time to clinical/radiographic healing (union)24 MonthsEvaluate time to clinical/radiographic healing (union vs. non-union) after a Titan 3D wedge procedure
Clinical complications24 MonthsComplications due to the procedure
Maintenance of implant position24 Months
Determine rate of removal of the device and subsequent healing24 Months
Change in anatomical and radiographic angular/positional alignment before and after an LCL procedure and/or medial cuneiform osteotomy using a TITAN 3-D™ Wedge24 Months
Maintenance of anatomical alignment24 Months
Change in AOFAS Ankle-Hindfoot and/or Midfoot Score across multiple time pointsPre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 monthsAmerican Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot clinical score. Pain: 0-40 points Function: 0-50 points Alignment: 0-10 points Total Score (sum): 0-100 points (higher score indicates better outcomes) American Orthopaedic Foot and Ankle Society (AOFAS) Midfoot clinical score. Pain: 0-40 points Function: 0-45 points Alignment: 0-15 points Total Score (sum): 0-100 points (higher score indicates better outcomes)
Change in PROMIS Pain Intensity Score across multiple time pointsPre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 monthsPatient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Score, Item Bank v1.0, SF 3a. Raw Score Range: 3 (no pain) to 15 (very severe pain)
Change in PROMIS Mobility Score across multiple time pointsPre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 monthsPatient-Reported Outcomes Measurement Information System (PROMIS) Mobility Score, Item Bank v2.0. Raw Score Range: 15 (high level of difficulty) to 120 (no difficulty)
Change in PROMIS Pain Interference Score across multiple time pointsPre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 monthsPatient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score, Item Bank v1.0, SF 6a. Raw Score Range: 6 (no interference) to 30 (high level of interference)
Compare the outcomes and complication rates of TITAN 3-D™ Wedges with previously published outcomes of historical controls, allograft bone and autograft bone24 Months
Change in VAS Pain Score across multiple time pointsPre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 monthsVisual Analog Scale (VAS). Line from 0 (no pain) to 10 (worst pain). Patient reported.
Determine bone reaction, if any, to the device such as overgrowth or cystic lesions24 Months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026